Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
- PMID: 38004480
- PMCID: PMC10675245
- DOI: 10.3390/ph16111615
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
Abstract
Antibiotics have revolutionized medicine, saving countless lives since their discovery in the early 20th century. However, the origin of antibiotics is now overshadowed by the alarming rise in antibiotic resistance. This global crisis stems from the relentless adaptability of microorganisms, driven by misuse and overuse of antibiotics. This article explores the origin of antibiotics and the subsequent emergence of antibiotic resistance. It delves into the mechanisms employed by bacteria to develop resistance, highlighting the dire consequences of drug resistance, including compromised patient care, increased mortality rates, and escalating healthcare costs. The article elucidates the latest strategies against drug-resistant microorganisms, encompassing innovative approaches such as phage therapy, CRISPR-Cas9 technology, and the exploration of natural compounds. Moreover, it examines the profound impact of antibiotic resistance on drug development, rendering the pursuit of new antibiotics economically challenging. The limitations and challenges in developing novel antibiotics are discussed, along with hurdles in the regulatory process that hinder progress in this critical field. Proposals for modifying the regulatory process to facilitate antibiotic development are presented. The withdrawal of major pharmaceutical firms from antibiotic research is examined, along with potential strategies to re-engage their interest. The article also outlines initiatives to overcome economic challenges and incentivize antibiotic development, emphasizing international collaborations and partnerships. Finally, the article sheds light on government-led initiatives against antibiotic resistance, with a specific focus on the Middle East. It discusses the proactive measures taken by governments in the region, such as Saudi Arabia and the United Arab Emirates, to combat this global threat. In the face of antibiotic resistance, a multifaceted approach is imperative. This article provides valuable insights into the complex landscape of antibiotic development, regulatory challenges, and collaborative efforts required to ensure a future where antibiotics remain effective tools in safeguarding public health.
Keywords: antibiotic resistance; bacterial evolution; bacterial mutation; drug designing; horizontal gene transfer; public and agricultural health.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Towards promising antimicrobial alternatives: The future of bacteriophage research and development in Saudi Arabia.J Infect Public Health. 2022 Dec;15(12):1355-1362. doi: 10.1016/j.jiph.2022.10.022. Epub 2022 Oct 28. J Infect Public Health. 2022. PMID: 36332378 Review.
-
Resilience Against Resistance: Exploring Cutting-edge Therapies for Methicillin-resistant Staphylococcus aureus (MRSA).Curr Med Chem. 2024 Oct 17. doi: 10.2174/0109298673316661241002060518. Online ahead of print. Curr Med Chem. 2024. PMID: 39421990
-
Nanotechnology-driven strategies to enhance the treatment of drug-resistant bacterial infections.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 May-Jun;16(3):e1968. doi: 10.1002/wnan.1968. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024. PMID: 38772565 Review.
-
Revolutionizing Antibiotic Delivery: Harnessing 3D-Printing Technology to Combat Bacterial Resistance.Curr Pharm Des. 2025 Jun 4. doi: 10.2174/0113816128365632250524160128. Online ahead of print. Curr Pharm Des. 2025. PMID: 40468934
-
Awareness and Knowledge of Antibiotic Resistance and Risks of Self-Medication With Antibiotics Among the Aseer Region Population, Saudi Arabia, 2023.Cureus. 2023 Jun 21;15(6):e40762. doi: 10.7759/cureus.40762. eCollection 2023 Jun. Cureus. 2023. PMID: 37485193 Free PMC article.
Cited by
-
Antibiotic Stewardship Program in a General Hospital in Abu Dhabi, UAE: Preparedness for the COVID-19 Pandemic.Cureus. 2024 Aug 20;16(8):e67270. doi: 10.7759/cureus.67270. eCollection 2024 Aug. Cureus. 2024. PMID: 39301392 Free PMC article.
-
Machine Learning in FTIR Spectrum for the Identification of Antibiotic Resistance: A Demonstration with Different Species of Microorganisms.Antibiotics (Basel). 2024 Aug 30;13(9):821. doi: 10.3390/antibiotics13090821. Antibiotics (Basel). 2024. PMID: 39334995 Free PMC article.
-
The clinical praxis of bacteriocins as natural anti-microbial therapeutics.Arch Microbiol. 2024 Oct 30;206(11):451. doi: 10.1007/s00203-024-04152-8. Arch Microbiol. 2024. PMID: 39476181 Review.
-
Mayan Medicinal Plants Bignonia potosina and Thouinia paucidentata Demonstrate Anti-Infective Properties Against the Priority Antibiotic-Resistant Bacteria Acinetobacter baumannii and Pseudomonas aeruginosa.Plants (Basel). 2024 Dec 14;13(24):3498. doi: 10.3390/plants13243498. Plants (Basel). 2024. PMID: 39771195 Free PMC article.
-
Antibacterial Potential of Honeybee Venom and Monascus purpureus Extracellular Metabolites Against Multidrug-Resistant Pathogenic Bacteria.Biology (Basel). 2024 Dec 28;14(1):21. doi: 10.3390/biology14010021. Biology (Basel). 2024. PMID: 39857252 Free PMC article.
References
-
- World Health Organization (WHO) Priority Medicines for Europe and the World/Warren Kaplan, Richard Laing 2004. [(accessed on 25 August 2023)]. Available online: https://iris.who.int/handle/10665/68769?show=full.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources